title: Hepoxilin A(3) facilitates neutrophilic breach of lipoxygenase-expressing airway epithelial barriers.
abstract: A feature shared by many inflammatory lung diseases is excessive neutrophilic infiltration. Neutrophil homing to airspaces involve multiple factors produced by several distinct cell types. Hepoxilin A(3) is a neutrophil chemoattractant produced by pathogen-infected epithelial cells that is hypothesized to facilitate neutrophil breach of mucosal barriers. Using a Transwell model of lung epithelial barriers infected with Pseudomonas aeruginosa, we explored the role of hepoxilin A(3) in neutrophil transepithelial migration. Pharmacological inhibitors of the enzymatic pathways necessary to generate hepoxilin A(3), including phospholipase A(2) and 12-lipoxygenase, potently interfere with P. aeruginosa-induced neutrophil transepithelial migration. Both transformed and primary human lung epithelial cells infected with P. aeruginosa generate hepoxilin A(3) precursor arachidonic acid. All four known lipoxygenase enzymes capable of synthesizing hepoxilin A(3) are expressed in lung epithelial cell lines, primary small airway epithelial cells, and human bronchial epithelial cells. Lung epithelial cells produce increased hepoxilin A(3) and lipid-derived neutrophil chemotactic activity in response to P. aeruginosa infection. Lipid-derived chemotactic activity is soluble epoxide hydrolase sensitive, consistent with hepoxilin A(3) serving a chemotactic role. Stable inhibitory structural analogs of hepoxilin A(3) are capable of impeding P. aeruginosa-induced neutrophil transepithelial migration. Finally, intranasal infection of mice with P. aeruginosa promotes enhanced cellular infiltrate into the airspace, as well as increased concentration of the 12-lipoxygenase metabolites hepoxilin A(3) and 12-hydroxyeicosa-5Z,8Z,10E,14Z-tetraenoic acid. Data generated from multiple models in this study provide further evidence that hepoxilin A(3) is produced in response to lung pathogenic bacteria and functions to drive neutrophils across epithelial barriers.
authors.affiliation: Mucosal Immunology Laboratory, Massachusetts General Hospital, Charlestown, MA 02129, USA.
authors.forename: David L
authors.initials: DL
authors.lastname: Tamang
authors.forename: Waheed
authors.initials: W
authors.lastname: Pirzai
authors.forename: Gregory P
authors.initials: GP
authors.lastname: Priebe
authors.forename: David C
authors.initials: DC
authors.lastname: Traficante
authors.forename: Gerald B
authors.initials: GB
authors.lastname: Pier
authors.forename: John R
authors.initials: JR
authors.lastname: Falck
authors.forename: Christophe
authors.initials: C
authors.lastname: Morisseau
authors.forename: Bruce D
authors.initials: BD
authors.lastname: Hammock
authors.forename: Beth A
authors.initials: BA
authors.lastname: McCormick
authors.forename: Karsten
authors.initials: K
authors.lastname: Gronert
authors.forename: Bryan P
authors.initials: BP
authors.lastname: Hurley
mesh_terms: D015126:8,11,14-Eicosatrienoic Acid / Q000031:analogs & derivatives* / Q000276:immunology / Q000378:metabolism; D000818:Animals; D001092:Arachidonate 12-Lipoxygenase / Q000276:immunology* / Q000378:metabolism; D015824:Blood-Air Barrier / Q000276:immunology* / Q000378:metabolism / Q000382:microbiology; D004847:Epithelial Cells / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D005260:Female; D006801:Humans; D008297:Male; D051379:Mice; D009504:Neutrophils / Q000276:immunology* / Q000378:metabolism; D018410:Pneumonia, Bacterial / Q000276:immunology / Q000378:metabolism; D011552:Pseudomonas Infections / Q000276:immunology* / Q000378:metabolism; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D020545:Respiratory Mucosa / Q000276:immunology / Q000378:metabolism / Q000382:microbiology; D057705:Transendothelial and Transepithelial Migration / Q000276:immunology*
chemical_list: C038243:8-hydroxy-11,12-epoxyeicosa-5,9,14-trienoic acid; D001092:Arachidonate 12-Lipoxygenase; D015126:8,11,14-Eicosatrienoic Acid